Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient. - Wikidata - awgldk - TriplyDB

Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.

Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.

http://www.wikidata.org/entity/Q35138344

about

Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway.Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009.Prognostic significance of chemotherapy-induced necrosis in osteosarcoma patients receiving pasteurized autografts.Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience.Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma.Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.Methotrexate Free Chemotherapy and Limb Salvage Surgery for Paediatric Osteosarcoma in India.The extremity localized classic osteosarcomas have better survival than the axial non-classics.Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.

P2860

Q26775998-A3B53F12-94EB-4431-827D-486FE528253D Q28554418-C1B1F6A0-99F2-4B34-904E-E9BC21B3C8D1 Q33618863-7958D51B-EC00-4133-9B3F-11EB414BCFEC Q36054721-842E9C7C-3A94-45F3-8B08-2DEB32A82FD9 Q36280076-195A38D6-7C88-4A5A-96B4-449D1766185C Q36556924-8134C04A-4552-437C-BEEA-7FB87A327DC6 Q38648115-2DE3AE74-FB47-41F8-8F47-27E78F728C30 Q47687686-21DEAAD2-B1B2-4224-89C5-CFE28E65383F Q49189268-A9B71BC4-9021-47E4-851B-E14696F3E76D Q50315172-335BABFD-ABDB-4888-A0C0-BC6BA00211D5 Q55279288-FAECD1EE-9F69-4C37-B6CA-F3FC3841991B

P2860

Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.

http://www.wikidata.org/entity/Q35138344

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Prognostic factors and treatme ...... eyond the "classical" patient.

@ast

Prognostic factors and treatme ...... eyond the "classical" patient.

@en

type

label

Prognostic factors and treatme ...... eyond the "classical" patient.

@ast

Prognostic factors and treatme ...... eyond the "classical" patient.

@en

prefLabel

Prognostic factors and treatme ...... eyond the "classical" patient.

@ast

Prognostic factors and treatme ...... eyond the "classical" patient.

@en

P1433

Q35138344-9503F8C7-2C8E-44B7-BE8C-C2E8F832E3C0

P1476

Q35138344-967B347D-4619-4222-9F19-536A87228A48

P2093

Q35138344-067D7363-279F-4B27-A78A-0202C5DBB67F

Q35138344-A675ADBE-2769-469B-A2B1-E492565B31DF

Q35138344-E5D8BC9E-D6B1-45EC-AFE3-3037B7411FBB

Q35138344-F9736B7D-3A0E-4BCE-A165-9EB6941279AC

P2860

Q35138344-03FC7FD2-C4D8-470D-B815-391C7B081EE8

Q35138344-0433878D-85E7-4271-872C-76A082BAB2F2

Q35138344-050365FC-1EA1-4FFD-BEE6-314698D6F7BD

Q35138344-062EAFC3-2069-4850-BBAF-84C43A71F22D

Q35138344-0928DCE2-8A88-46F3-AA42-E0C48EACCD39

Q35138344-09CBC182-C3FA-4C33-A354-9B35BFAFC687

Q35138344-0FC61C93-4D8F-43F1-AEE5-D5C88D812A77

Q35138344-1282C562-76CD-4FA1-843C-E6C0EBFD18CC

Q35138344-12A53B14-3E70-4FE4-9B7B-83D018DB1D48

Q35138344-12B8244A-B6DA-4150-B931-7C94A37E25E0

P304

Q35138344-B1EA4E71-83D4-451C-8F58-775503F50D04

P31

Q35138344-A43FA4E3-23F7-4D80-89FC-5CB2E818067A

P356

Q35138344-E2356659-005B-4EB7-814A-E698B77C6E51

P478

Q35138344-D80220A5-3154-48DE-9703-3A09B05D8550

P50

Q35138344-480D598E-88DB-40B2-AAB2-298A686FC718

Q35138344-57863FCE-1588-4156-B4BD-8843886C3ED7

P577

Q35138344-77EB01EE-7B08-457E-BAE2-8FE3C1029417

P5875

Q35138344-65838AD5-F864-4FD2-B681-18D8836F8702

P698

Q35138344-EC7A4048-5D91-4BA9-BA47-BD71D6065CF4

P932

Q35138344-BDBE020E-8FE6-4EEC-A898-F093B6CA9E80

P356

P1433

P1476

Prognostic factors and treatme ...... beyond the "classical" patient

@en

P2093

Harald Weedon-Fekjær

http://www.w3.org/2001/XMLSchema#string

Kjetil Berner

http://www.w3.org/2001/XMLSchema#string

Odd R Monge

http://www.w3.org/2001/XMLSchema#string

Olga Zaikova

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good R

Incidence and survival of malignant bone sarcomas in England 1979-2007.

The geographic variation of the incidence of malignant primary bone tumors in Sweden.

Orthopedic surgery options for the treatment of primary osteosarcoma.

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Evaluation of survival data and two new rank order statistics arising in its consideration.

Osteosarcoma treatment - where do we stand? A state of the art review.

P304

516843

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/516843

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Øyvind Sverre Bruland

Kirsten Sundby Hall

P577

2015-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273501557

http://www.w3.org/2001/XMLSchema#string

P698

25784831

http://www.w3.org/2001/XMLSchema#string

P932

4346701

http://www.w3.org/2001/XMLSchema#string